1 – Canadian Cystic Fibrosis Patients See Access to Orkambi Delayed for Undetermined Time
Canadian patients with cystic fibrosis will have to wait longer for access to Orkambi (lumacaftor/ivacaftor). The submission for the therapy will be reconsidered at a future meeting by the Canadian Drug Expert Committee of the Canadian Agency for Drugs and Technologies in Health.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?